• 검색 결과가 없습니다.

Relapsing lupus enteritis in systemic lupus erythematosus

N/A
N/A
Protected

Academic year: 2021

Share "Relapsing lupus enteritis in systemic lupus erythematosus"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

Images in Practice

Relapsing lupus enteritis in systemic lupus erythematosus

Systemic lupus erythematosus (SLE) is a systemic autoim- mune disease and has systemic features that can affect all or- gans. Steroid therapy is an essential treatment option in SLE involving the kidneys, other internal organs, or central nervous system.

A 42-year-old woman with a 10-year history of SLE pre- sented with nonspeci fic nausea, vomiting, and diarrhea. She experienced lupus enteritis 7 years earlier, which was cured with steroid treatment and, since then, had demonstrated sta- ble disease with steroid and disease-modifying antirheumatic drug treatment. Vital signs were stable, and there were no signs of surgical abdomen. Laboratory investigations were normal except for C3 and C4 (69.2 and 7.2 mg/dL, respectively). Abdom- inal computed tomography revealed typical target sign indi- cating inflammatory edema of the small bowel (Fig. 1). The patient recovered completely after immediate treatment with steroid pulse therapy under a diagnosis of lupus enteritis.

Lupus enteritis can present with nonspeci fic symptoms and can lead to fatal intestinal bleeding or perforation. Thus, it is important to diagnose lupus enteritis and start treatment as early as possible. If a patient with SLE presents with nonspe- ci fic symptoms such as abdominal pain and diarrhea, lupus

activity should be investigated under the suspicion of lupus enteritis.

Conflicts of interest

All authors have no con flicts of interest to declare.

Yaerim Kim, Seungyeup Han

*

Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Kidney Institute, Daegu, Korea

*

Corresponding author. Department of Internal Medicine, Keimyung University School of Medicine, Keimyung University Kidney Institute, 56 Dalseong-ro, Jung-gu, Daegu 41931, Korea.

E-mail address: hansy@dsmc.or.kr (S Han).

20 January 2016 Available online 21 March 2016

Figure 1. Abdominal CT of the patient on admission. CT shows circumferential submucosal thickening and swelling of the small bowel wall with alternating layers of high and low attenuation, which is referred to as target sign.

CT, computed tomography.

Kidney Research and Clinical Practice

j o u r n a l h o m e p a g e : h t t p : / / w w w . k r c p - k s n . c o m Content s li sts a v a il able at S c i e n c e D i r e c t

Kidney Res Clin Pract 35 (2016) 127

http://dx.doi.org/10.1016/j.krcp.2016.03.001

2211-9132/Copyright © 2016. The Korean Society of Nephrology. Published by Elsevier. This is an open access article under the CC BY-NC-ND license

(http://creativecommons.org/licenses/by-nc-nd/4.0/).

수치

Figure 1. Abdominal CT of the patient on admission. CT shows circumferential submucosal thickening and swelling of the small bowel wall with alternating layers of high and low attenuation, which is referred to as target sign.

참조

관련 문서

surveillance study of patients with Emergency Department injuries under the control of the Korea Centers for Disease Control and Prevention (KCDC).Statistical

Serum uric acid levels and risk for vascular disease in patients with metabolic syndrome... Prevalence if the metabolic syndrome in a Turkish

 Although van der Waals equation is still less accurate at high

* HCI: Host Controller Interface.. WIRELESS NETWORKING, 430.752B, 2020 SPRING SEOUL NATIONAL

Chronic kidney disease (partial update): Early identification and management of chronic kidney disease in adults in primary and secondary care (Clinical

The antagonist SH-1 was somewhat effective to control common scab in the potato field with low occurrence of the disease... acidiscabies로

In this study, a titanium surface was modified with acrylic acid (AA) using a plasma treatment and immobilized with bioactive arginine- glycine-aspartic acid (RGD) peptide,

Results: In this research, in the group with fibromyalgia patients group, systemic lupus erythematosus patients group and without systemic autoimmune